LCDR Ramanadham is currently the Senior Scientific Advisor for the Office of Pharmaceutical Manufacturing Assessment, within the Office of Pharmaceutical Quality. He is primarily responsible for the strategic oversight and implementation of emerging policies and initiatives. He joined the Agency in November 2009 after graduating with his Doctor of Pharmacy degree from the University of Maryland and his M.B.A. from the University of Baltimore. Prior to joining FDA, LCDR Ramanadham had experience in solid oral dosage manufacturing ranging from OTC products to schedule II narcotics. Outside of FDA, LCDR Ramanadham continues to practice pharmacy in the community setting to maintain perspective on the clinical relevancy and impact of our efforts in pharmaceutical quality.